Springer DM - Search Results

1

Anti-MRSA cephems. Part 3: additional C-7 acid derivatives.

Springer DM, Luh BY, Goodrich JT, Bronson JJ. Springer DM, et al. Bioorg Med Chem. 2003 Jan 17;11(2):281-91. doi: 10.1016/s0968-0896(02)00335-8. Bioorg Med Chem. 2003. PMID: 12470721

2

Anti-MRSA cephems. Part 2: C-7 cinnamic acid derivatives.

Springer DM, Luh BY, Goodrich J, Bronson JJ. Springer DM, et al. Bioorg Med Chem. 2003 Jan 17;11(2):265-79. doi: 10.1016/s0968-0896(02)00336-x. Bioorg Med Chem. 2003. PMID: 12470720

3

Synthesis and activity of a C-8 keto pleuromutilin derivative.

Springer DM, Sorenson ME, Huang S, Connolly TP, Bronson JJ, Matson JA, Hanson RL, Brzozowski DB, LaPorte TL, Patel RN. Springer DM, et al. Bioorg Med Chem Lett. 2003 May 19;13(10):1751-3. doi: 10.1016/s0960-894x(03)00297-x. Bioorg Med Chem Lett. 2003. PMID: 12729657

4

Cyclopentanone ring-cleaved pleuromutilin derivatives.

Springer DM, Bunker A, Luh BY, Sorenson ME, Goodrich JT, Bronson JJ, DenBleyker K, Dougherty TJ, Fung-Tomc J. Springer DM, et al. Eur J Med Chem. 2007 Jan;42(1):109-13. doi: 10.1016/j.ejmech.2006.07.018. Epub 2006 Dec 6. Eur J Med Chem. 2007. PMID: 17156897

5

Biaryl diacid inhibitors of human s-PLA2 with anti-inflammatory activity.

Springer DM, Luh BY, Bronson JJ, McElhone KE, Mansuri MM, Gregor KR, Nettleton DO, Stanley PL, Tramposch KM. Springer DM, et al. Bioorg Med Chem. 2000 May;8(5):1087-109. doi: 10.1016/s0968-0896(00)00047-x. Bioorg Med Chem. 2000. PMID: 10882020

6

Anti-MRSA cephems. Part 1: C-3 substituted thiopyridinium derivatives.

Springer DM, Luh BY, Bronson JJ. Springer DM, et al. Bioorg Med Chem Lett. 2001 Mar 26;11(6):797-801. doi: 10.1016/s0960-894x(01)00060-9. Bioorg Med Chem Lett. 2001. PMID: 11277523

7

Chemical conversion of nocathiacin I to nocathiacin II and a lactone analogue of glycothiohexide alpha.

Connolly TP, Regueiro-Ren A, Leet JE, Springer DM, Goodrich J, Huang XS, Pucci MJ, Clark JM, Bronson JJ, Ueda Y. Connolly TP, et al. Among authors: springer dm. J Nat Prod. 2005 Apr;68(4):550-3. doi: 10.1021/np040225d. J Nat Prod. 2005. PMID: 15844946

8

Design at the atomic level: generation of novel hybrid biaryloxazolidinones as promising new antibiotics.

Zhou J, Bhattacharjee A, Chen S, Chen Y, Duffy E, Farmer J, Goldberg J, Hanselmann R, Ippolito JA, Lou R, Orbin A, Oyelere A, Salvino J, Springer D, Tran J, Wang D, Wu Y, Johnson G. Zhou J, et al. Bioorg Med Chem Lett. 2008 Dec 1;18(23):6179-83. doi: 10.1016/j.bmcl.2008.10.014. Epub 2008 Oct 7. Bioorg Med Chem Lett. 2008. PMID: 18951792

9

Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics.

Zhou J, Bhattacharjee A, Chen S, Chen Y, Duffy E, Farmer J, Goldberg J, Hanselmann R, Ippolito JA, Lou R, Orbin A, Oyelere A, Salvino J, Springer D, Tran J, Wang D, Wu Y, Johnson G. Zhou J, et al. Bioorg Med Chem Lett. 2008 Dec 1;18(23):6175-8. doi: 10.1016/j.bmcl.2008.10.011. Epub 2008 Oct 7. Bioorg Med Chem Lett. 2008. PMID: 18947996

10

An update on inhibitors of human 14 kDa Type II s-PLA2 in development.

Springer DM. Springer DM. Curr Pharm Des. 2001 Feb;7(3):181-98. doi: 10.2174/1381612013398275. Curr Pharm Des. 2001. PMID: 11311112 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters